India Pesticides Limited has successfully completed its postal ballot process and submitted the voting results along with the scrutinizer's report to stock exchanges on March 09, 2026. The company conducted the postal ballot through remote e-voting pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Postal Ballot Process Overview

The remote e-voting process commenced on Thursday, February 05, 2026 at 9:00 a.m. (IST) and concluded on Friday, March 06, 2026 at 5:00 p.m. (IST). The company appointed Saket Sharma, Partner at GSK & Associates Company Secretaries, as the scrutinizer for the postal ballot process.

Resolution Results and Voting Outcomes

All three special resolutions were passed with overwhelming majority support from shareholders across different categories. The postal ballot witnessed significant participation with 65.39% of total outstanding shares participating in the voting process.

Resolution 1: Re-appointment of Dr. Madhu Dixit

The first resolution concerned the re-appointment of Dr. Madhu Dixit (DIN: 08495360) as Non-Executive Independent Director & Chairperson for a second term of five consecutive years.

Resolution 2: Re-appointment of Mr. Mohan Vasant Tanksale

The second resolution addressed the re-appointment of Mr. Mohan Vasant Tanksale (DIN: 02971181) as Non-Executive Independent Director for a second term of five consecutive years.

Resolution 3: Regularization of Mr. Arun Kumar Jain

The third resolution involved the regularization of Mr. Arun Kumar Jain (DIN: 07563704) as Non-Executive Independent Director for a first term of five consecutive years.

Scrutinizer's Report and Compliance

Saket Sharma, the appointed scrutinizer, submitted his comprehensive report confirming that all resolutions were duly passed with requisite majority. The scrutinizer's report detailed the voting process, including the unblocking of votes on March 06, 2026 at 05:57 P.M. in the presence of two witnesses who are not in the employment of the company.

Regulatory Submission and Documentation

The company submitted the voting results to BSE Limited (Company Code: 543311) and National Stock Exchange of India Limited (Symbol: IPL) on March 09, 2026. The submission was made by Narendra Dev Nath Ojha, Company Secretary and Compliance Officer, fulfilling all regulatory disclosure requirements under SEBI regulations.

All electronic data and records of e-voting will remain in the scrutinizer's custody until the Chairman considers, approves and signs the minutes of the postal ballot. The process was conducted in accordance with Section 108 and 110 of the Companies Act, 2013, and relevant rules under the Companies (Management and Administration) Rules, 2014.

India Pesticides Limited has released the complete transcript of its Q3 FY26 earnings conference call held on February 11, 2026, showcasing robust financial performance for the quarter ended December 31, 2025. The company delivered strong growth across key metrics with significant improvements in both revenue and profitability.

Strong Q3 FY26 Financial Performance

The company reported impressive financial results for the third quarter, demonstrating consistent growth momentum and operational efficiency improvements.

Nine-Month Performance Highlights

For the nine-month period ended December 2025, India Pesticides demonstrated exceptional growth across all financial parameters, reflecting strong operational leverage and cost efficiency measures.

Market Segmentation and Geographic Performance

The company maintained a balanced revenue mix with technical and API products contributing 73% and formulations accounting for 27% of Q3 FY26 revenue. Export sales showed robust growth of 28%, reaching ₹96 crores compared to ₹75 crores in Q3 FY25, driven by strong demand in Europe and Australia. Domestic sales increased by 33% to ₹130 crores, supported by higher demand for herbicides and intermediates.

Capacity Expansion and Strategic Initiatives

Management highlighted significant progress in capacity expansion initiatives. The Shalvis facility has commenced commercial production of technical products, with expectations to contribute ₹80 crores to ₹100 crores in revenue for the next financial year. The company's intermediate Pretilachlor PEDA plant has been commissioned with expanded capacity, with PEDA and Pretilachlor combined contributing ₹50 crores to ₹60 crores in Q3.

Future Growth Roadmap

CEO D.K. Jain outlined the company's ambitious growth strategy, targeting ₹3,000 crores revenue by March 2031. The roadmap includes ₹1,000-1,100 crores from Hamirpur facility, ₹1,500 crores from existing Sandila and Dewa Road units, and ₹500 crores from B2C branded sales. For FY27, the company expects approximately 20% revenue growth while maintaining EBITDA margins in the 18-20% range.

Regulatory Compliance and Documentation

The earnings call transcript was submitted to BSE Limited and National Stock Exchange of India Limited on February 17, 2026, in compliance with Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript is also available on the company's website at www.indiapesticideslimited.com , ensuring transparent communication with all stakeholders.